Observational studyDiabetologia2019

The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study.

Stuart J McGurnaghan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.